Showing results (751-760 of 8,958) with videos related to
Sort By:
Pageof 896
Journal of Hepatology|December 17, 2016
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitisPartha Mukhopadhyay, Béla Horváth, Mohanraj Rajesh, et al.Journal of Hepatology|May 8, 2014
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapyJames R Burton, Jacqueline G O'Leary, Elizabeth C Verna, et al.Journal of Hepatology|May 8, 2014
Hepatitis B virus PreS/S gene variants: pathobiology and clinical implicationsTeresa Pollicino, Irene Cacciola, Francesca Saffioti, et al.Journal of Hepatology|May 8, 2014
CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathwayQichao Huang, Jibin Li, Jinliang Xing, et al.Journal of Hepatology|September 29, 2016
Personalized treatment of patients with very early hepatocellular carcinomaAlessandro Vitale, Markus Peck-Radosavljevic, Edoardo G Giannini, et al.Journal of Hepatology|March 22, 2017
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapyPeter R Galle, Francesco Tovoli, Friedrich Foerster, et al.Journal of Hepatology|March 22, 2017
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinomaAo Huang, Xin Zhao, Xin-Rong Yang, et al.Journal of Hepatology|March 22, 2017
Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factorThomas Jacob Urban, Paola Nicoletti, Naga Chalasani, et al.Journal of Hepatology|December 1, 1987
Anti-HBc IgM in cases of hepatocellular carcinoma and cirrhosis in TaiwanM Roggendorf, L Y Hwang, R P Beasley, et al.Journal of Hepatology|March 25, 2017
Global trends and predictions in hepatocellular carcinoma mortalityPaola Bertuccio, Federica Turati, Greta Carioli, et al.Pageof 896